Atrial Fibrillation and Cancer: Where Biology and Epidemiology Intertwine

Affiliations

¹ Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
² Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.

Editorial

Konstantinos C Siontis et al. JACC CardioOncol. 2021.

. 2021 Jun 15;3(2):233-235.

doi: 10.1016/j.jaccao.2021.04.003. eCollection 2021 Jun.

¹ Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
² Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.

No abstract available

Keywords: atrial fibrillation; cancer; epidemiology; pathogenesis.

Conflict of interest statement

All authors have reported that they have no relationships relevant to the contents of this paper to disclose.

1. Yuan M., Zhang Z., Tse G. Association of cancer and the risk of developing atrial fibrillation: a systematic review and meta-analysis. Cardiol Res Pract. 2019;2019:8985273. - PMC - PubMed
1. Farmakis D., Parissis J., Filippatos G. Insights into onco-cardiology: atrial fibrillation in cancer. J Am Coll Cardiol. 2014;63:945–953. - PubMed
1. Conen D., Wong J.A., Sandhu R.K. Risk of malignant cancer among women with new-onset atrial fibrillation. JAMA Cardiol. 2016;1:389–396. - PMC - PubMed
1. Yun J.P., Choi E.-K., Han K.-D. Risk of atrial fibrillation according to cancer type: a nationwide population-based study. J Am Coll Cardiol CardioOnc. 2021;3:221–232. - PMC - PubMed
1. Jakobsen C.B., Lamberts M., Carlson N. Incidence of atrial fibrillation in different major cancer subtypes: a nationwide population-based 12 year follow up study. BMC Cancer. 2019;19:1105. - PMC - PubMed